ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Sudarshan Pharma Industries Ltd has scheduled a board meeting for August 12, 2026, to consider and approve the financial results for the quarter ended June 30, 2026.
Sudarshan Pharma's Warrants Committee meeting postponed from 11 June to 12 June 2026. The delay is procedural and does not affect the underlying warrant conversion agenda.
Sudarshan Pharma Industries scheduled a Warrants Committee meeting for June 11, 2026. The committee will consider converting warrants and allotting equity shares to applicants.
Sudarshan Pharma pre-poned its board meeting to May 21, 2026, to consider migrating from the BSE SME platform to the main boards of BSE and NSE.
Sudarshan Pharma Industries scheduled a board meeting for May 22, 2026. Directors will consider migrating equity shares from BSE SME to the Main Board.
Sudarshan Pharma scheduled a board meeting for May 15, 2026, to consider issuing Foreign Currency Convertible Bonds. The proposal remains subject to regulatory and statutory approvals.
Sudarshan Pharma Industries Ltd has scheduled a Board Meeting on April 30, 2026. The board will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed for 48 hours post-declaration.